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Id2 deletion attenuates Apc-deficient ileal tumor formation
Kyoko Biyajima1,‡, Fumihiko Kakizaki2, Xiaodong Shen1, Kentaro Mori1, Manabu Sugai1, M. Mark Taketo2
and Yoshifumi Yokota1,*
ABSTRACT
The expression level of inhibitor of DNA binding 2 (Id2) is increased in
colorectal carcinomas and is positively correlated with poor
prognosis. However, the functional significance of Id2 in intestinal
tumorigenesis has not been fully defined using genetic approaches.
Here, we show that Id2 promotes ileal tumor initiation in Apc-deficient
mice. Expression of Id2 was stimulated by Wnt signaling through the
enhancer region of the Id2 promoter at the early stage of
tumorigenesis in Apc+/Δ716 (ApcΔ716) mice. Genetic depletion of Id2
inApcΔ716 mice caused∼80% reduction in the number of ileal polyps,
but had little effect on tumor size. Notably, the lack of Id2 increased
the number of apoptotic cells in the normal crypt epithelium of the
mice. Furthermore, DNA microarray analysis revealed that the
expression level of Max dimerization protein 1 (Mxd1), known as a
c-Myc antagonist, was specifically increased by Id2 deletion in the
ileal intestinal epithelium ofApcΔ716 mice. In contrast, the protein level
of c-Myc, but not the mRNA level, was decreased by loss of Id2 in
these mice. These results indicate that loss of Id2 inhibits tumor
initiation by up-regulation of Mxd1 and down-regulation of c-Myc in
ApcΔ716 mice.
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INTRODUCTION
Somatic mutation of the adenomatous polyposis coli (APC) tumor
suppressor gene occurs in most colorectal cancers, and is an early
event in the development of sporadic colorectal cancer (Powell
et al., 1992). A germ-line mutation of APC is also responsible for
the genetic disorder familial adenomatous polyposis (FAP)
(Kinzler and Vogelstein, 1996; Taketo and Edelmann, 2009).
Mutation of APC leads to activation of Wnt signaling via β-catenin
stabilization. The accumulated β-catenin then translocates to the
nucleus where it stimulates the expression of Wnt target genes
through interaction with T-cell factor/lymphocyte enhancer factor
(TCF/LEF) transcription factors (Fodde et al., 2001).
Id2, a member of the Id family, has a helix-loop-helix (HLH)
motif but lacks a DNA-binding domain. Therefore, Id2 proteins
prevent bHLH proteins from interacting with DNA in a dominant
negative manner (Ruzinova and Benezra, 2003; Yokota and Mori,
2002). Since bHLH transcription factors play an important role in
multiple processes of cell differentiation and proliferation, Id2 is
also involved in these processes (Ruzinova and Benezra, 2003;
Yokota, 2001). The expression level of Id2 is generally low in
normal adult tissues. However increased expression of Id2 is
observed in various human cancers including colorectal cancer, and
often correlates with poor prognosis (Gray et al., 2008; Perk et al.,
2005; Rockman et al., 2001; Wilson et al., 2001). Interestingly,
previous studies have shown that transcription from the ID2
promoter is increased by overexpression of β-catenin (Rockman
et al., 2001). Electrophoretic mobility shift assays have also revealed
that the ID2 promoter contains a functional TCF-4 binding site
(Rockman et al., 2001). Furthermore, knockdown of Id2 expression
not only inhibits proliferation but also induces apoptosis in
colorectal cancer cells that have mutations in components of the
Wnt signaling pathway (Gray et al., 2008). On the other hand,
overexpression of Id2 increases anchorage-independent survival of
colon cancer cells (Rockman et al., 2001). These circumstantial
evidences suggest that Id2 is likely to be important for colorectal
tumorigenesis in vivo. However, the functional significance of Id2
in intestinal tumorigenesis has not been fully defined using genetic
approaches.
To elucidate the physiological role of Id2 in intestinal
tumorigenesis using a genetic approach, we introduced an Id2
null mutation into ApcΔ716 mice, a model for human FAP (Oshima
et al., 1995a; Yokota et al., 1999). We have demonstrated here that
Id2 plays an essential role in ileal tumor initiation in ApcΔ716 mice.
RESULTS
Expression of Id2 is stimulated at early stages of polyp
formation in ApcΔ716 mice
To investigate the potential role of Id2 in intestinal tumorigenesis,
we first determined the mRNA levels of Id2 in the tumor epithelium
of ApcΔ716 mice by qRT-PCR analysis. The tumor and adjacent
normal epithelia were collected by laser microdissection. As shown
in Fig. 1A, the level of Id2 in the microadenoma epithelium
(≤0.5 mm in diameter) was 5 times higher than that in normal crypts
in ApcΔ716 mice. We also found that tumor epithelial cells from
adenomas larger than 0.5 mm in diameter showed essentially the
same level of Id2 mRNA as that in microadenomas (Fig. 1A).
Consistent with the qRT-PCR data, the levels of Id2 protein in
ApcΔ716 adenomas were 3 times higher than that in the adjacent
normal intestinal tissues (Fig. 1B). It has been reported that ID2 is a
downstream target gene of Wnt signaling in human colon cancer
cell lines (Rockman et al., 2001). To determine if mouse Id2 is also a
target gene of Wnt signaling, we performed ChIP-PCR analysis of
the binding of Tcf4 to the promoter region of the Id2 gene.
Sequencing analysis revealed ten putative Tcf/Lef-binding
consensus sequences in the Id2 promoter region spanning from
−4000 to −1 (Fig. 1C; supplementary material Fig. S1). As
expected, Tcf4 bound to the DNA region spanning from −3300 to
−3146 of the Id2 distal promoter (Fig. 1D). We also confirmed the
binding of Tcf4 to the promoter region of the known β-catenin targetReceived 5 April 2015; Accepted 2 June 2015
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Fig. 1. Expression of Id2 is increased in the intestinal tumor epithelial cells of ApcΔ716 mice. (A) Expression level of Id2 mRNA determined by qRT-PCR.
Epithelial cells were collected by laser-microdissection from intestinal polyps and adjacent normal crypts (crypt epithelial cells) of ApcΔ716 mice. Microadenomas
(mAd) and adenomas 1 mm, 2 mm and >2 mm in diameter were analyzed. The results are given as means±s.d. (n=3). **P<0.01. (B) Expression level of the Id2
protein in intestinal polyps and adjacent normal tissues of ApcΔ716 and Apc Id2 mice was analyzed by western blotting. N, normal tissue; P, polyp. Open
arrowhead, nonspecific band; closed arrowhead, endogenous Id2. β-actin, loading control. (C) Schematic representation of the locus of the Id2 enhancer region
(Id2 enh) in the Id2 promoter. The gray rectangle indicates the first exon of Id2. The numbers indicate the distance from the Id2 transcriptional start site. The open
arrowheads indicate Tcf/Lef binding consensus sequences. (D,E) ChIP assays. Chromatin from small intestinal polyps of ApcΔ716 mice was immunoprecipitated
with antibodies against Tcf4 or IgG as a control, followed by qPCR using (D) primer pairs (#1–#3) spanning the mouse Id2 promoter locus shown in C or (E)
primers specific for the Axin2 promoter. The results are presented as percentage immunoprecipitated over input and are representative of three independent
experiments. N.D., not detected. The results are given as means±s.d. (F) Schematic representation of the luciferase (Luc) expression constructs containing the
Id2 enhancer with/without a CMV-minimal promoter (mPro). (G) Luciferase reporter gene assays for active β-catenin mediated activation of the CMV-mPro.
HCT116 (left) or SW480 (right) cells were transfected with a reporter construct and an expression vector for active β-catenin and TCF4. Bars indicate relative
luciferase activities calibrated to those of the promoter-less luciferase construct. Error bars show standard deviation of triplicate samples. Empty, promoter-less
luciferase construct; mPro, luciferase construct containing only CMV minimal promoter; Id2 Enh, luciferase construct containing the CMV minimal promoter and
Id2 DNA fragment of −3641 to −3136. **P<0.01.
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gene Axin2 (Fig. 1E). To test this Tcf4 binding region for enhancer
activity, we conducted luciferase reporter assays using the
constructs shown in Fig. 1F. The putative Id2-enhancer fragment
significantly activated Wnt-signaling dependent transcription from
the CMV minimal promoter in two colorectal cancer cell lines
(HCT116 and SW480) (Fig. 1G). Therefore, these results indicate
that Id2 expression is stimulated by Wnt signaling through the
enhancer region, in tumor epithelial cells of ApcΔ716 mice at an early
stage of tumorigenesis.
Loss of Id2 inhibits ileal tumor initiation of ApcΔ716 mice
To determine the role of increased Id2 expression in the
tumorigenesis of Apc-deficient intestinal adenomas, we crossed the
ApcΔ716 mice with Id2−/− mice twice to generate Apc+/Δ716 Id2−/−
(Apc Id2) mice. Because Id2−/− mice are perinatal lethal on a
C57BL/6 background (Ghosh et al., 2014), the ApcΔ716 allele on the
C57BL/6 background was transferred to the 129/Sv genetic
background. As shown in Fig. 1B, expression of Id2 protein could
not be detected in the normal intestinal tissues or intestinal polyps of
the Apc Id2 mice. Due to intestinal distortion between the jejunum
and ileum caused by loss of Id2 (Russell et al., 2004), the Apc Id2
mice became moribund around 16 weeks of age. We therefore
euthanized these mutant mice at this age. Since the ApcΔ716 mice in
the 129/Sv genetic background formed few polyps in the colon at
this age, we therefore focused on small intestinal polyps in these
mice. Notably, loss of Id2 resulted in a markedly decreased ileal
polyp number in ApcΔ716 mice (Fig. 2A,B). Specifically, the ApcΔ716
mice developed 55±15 ileal polyps at the age of 16 weeks. On the
other hand, in Apc Id2 mutant mice of the same age, the total ileal
polyp number was significantly lower (8±4 polyps), showing an
80% reduction in the number found in the ApcΔ716 mice (P=0.0001
Fig. 2B). Interestingly, there was essentially no difference in the
number of tumors in the duodenum or the jejunum between the two
mutant mice (supplementary material Fig. S2A,B). To further
evaluate the effect of the loss of Id2 in the early stage of
tumorigenesis in the ApcΔ716 mice, we compared the number
of microadenomas between the ApcΔ716 andApc Id2mice at 4 weeks
of age, before any macroscopically visible tumors could be
observed. As shown in supplementary material Fig. S2C, the
ApcΔ716 mice had formed 4±0.9 polyps in the ileum by 4 weeks of
age. In contrast, the number of polyps in the littermate Apc Id2mice
was 25% that of the ApcΔ716 mice of the same age (1±0.6 polyps,
P=0.00009. supplementary material Fig. S2C). Since knockdown of
Id2 was reported to suppress the proliferation of colon cancer cells
(Gray et al., 2008), we next determined polyp size distribution in
these mice. We found that the percentage of ileal polyps with a
diameter of 0.5–1 mm in the Apc Id2mice was lower than that in the
ApcΔ716 mice (ApcΔ716, 47% versus Apc Id2, 34%;P=0.02; Fig. 2C).
Furthermore, the percentage of polyps with a diameter of less than
0.5 mm in the Apc Id2 mice was higher than in the ApcΔ716 mice
(ApcΔ716, 45% versus Apc Id2, 59%; P=0.02; Fig. 2C). However,
there was no difference in the percentage of large (1−2 mm) ileal
polyps between the twomutant mice (Fig. 2C). These results indicate
that Id2 deficiency has a much smaller effect on tumor size than it
has on tumor number and that Id2 plays an important role in ileal
tumor initiation in ApcΔ716 mice.
It has been reported that Id2−/− mice also form intestinal polyps
(Russell et al., 2004). Because it is known that loss of
heterozygosity (LOH) of Apc stabilizes β-catenin and promotes its
nuclear accumulation, nuclear β-catenin expression was observed in
Apc loss-induced epithelial adenoma (supplementary material
Fig. S3C). However, nuclear β-catenin accumulation was not
Fig. 2. Loss of Id2 attenuates ileal
tumor formation in ApcΔ716 mice.
(A) Representative Swiss rolls of the ileum
from ApcΔ716 and Apc Id2 mice stained with
H&E. Arrowheads indicate polyps. Scale
bars, 1 mm. (B) Total number of polyps in the
ApcΔ716 andApc Id2mice at 16 weeks of age
as assessed using a dissecting microscope.
The results shown are the mean number of
polyps/mouse±s.d. (n=7–8). **P<0.01.
(C) Size distribution of the polyps. Polyps
were classified according to their diameter in
millimeters. The results are shown as
percentages for the respective size classes
(n=7–8). Φ indicates polyp diameter.
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detected in Id2 loss-induced epithelial tumor cells (supplementary
material Fig. S3F). Because of these differences, Apc-deficient
adenomas can be distinguished from Id2 loss-induced polyps in Apc
Id2 mice. β-catenin staining revealed that the percentage of Apc-
deficient adenomas was ∼96% in Apc Id2 mice (supplementary
material Table S1). This result suggests that the tumors derived from
Id2 loss are negligible in number in this analysis.
The Id2 protein is specifically expressed in the intestinal
crypt epithelium
It has been reported that polyp formation is initiated byLOHat theApc
locus in the proliferative zone cells of the intestinal crypts of ApcΔ716
mice (Oshima et al., 1995a). To determine if Id2 is expressed in
intestinal crypts, we assessed its protein expression level along the
crypt-villus axis of the intestinal epithelium in these mice. We first
separated the normal villus and crypt epithelium from the surrounding
tissue. H&E staining showed that villi and crypts were successfully
isolated (Fig. 3A).Western blotting showed prominent Id2 expression
in the crypt epithelium but not in the villus epithelium within the
normal epithelial compartment of the ApcΔ716 mice (Fig. 3B).
Because the loss of Id2 specifically suppresses ileal tumor
initiation in ApcΔ716 mice, we confirmed the expression patterns of
Id2 and other Id-family members (Id1 and Id3) along the proximal-
distal axis of the small intestine. The expression levels of Id1, Id2,
and Id3 remained unchanged throughout the small intestine,
although the levels of Id1 and Id3 were increased by Id2 deletion
(supplementary material Fig. S4A-C). These results indicate that the
ileal specific phenotype is not attributable to different expression
patterns among Id-family members along the proximal-distal axis of
the small intestine.
It is known that an additional mutation in the Cdx2 gene in
ApcΔ716 mice reverses polyp localization, shifting most polyps to
the colon (Taketo and Edelmann, 2009). It has also been reported
that a conditional mutation in theGata4 gene in the jejunum of adult
mice results in a partial jejunal-to-ileal transformation (Bosse et al.,
2006). We therefore evaluated the expression of the Gata4, Cdx1,
and Cdx2 genes. However, the expression levels of Gata4, Cdx1,
and Cdx2 were not altered by the loss of Id2 (supplementary
material Fig. S5). These results suggest that Id2 promotes ileal
tumor initiation in the proliferating crypt epithelium of ApcΔ716
mice without the effect on the location of the polyps.
Id2 promotes ileal tumor initiation through inhibition of
apoptosis in intestinal crypts of ApcΔ716 mice
To analyze the mechanism of Id2-mediated tumor initiation,
we next investigated the effect of Id2-deficiency on the
proliferation and apoptosis of normal crypt cells of ApcΔ716 mice.
Immunohistochemistry of cleaved caspase-3, which is a marker of
apoptosis, revealed that the rate of apoptotic cells per 100 crypts in
Apc Id2 mice was 3.7 times higher than that in ApcΔ716 mice.
(ApcΔ716, 2.6±1.5 versus Apc:Id2, 9.7±3.8; P=0.04; Fig. 4A,B). On
the other hand, loss of Id2 did not affect apoptosis of villus epithelial
cells in ApcΔ716 mice (Fig. 4C,D). Furthermore, there was no
difference in the percentage of Ki67 positive cells in normal crypt
epithelium between ApcΔ716 and Apc Id2 mice. (ApcΔ716, 82±4.1
versus Apc:Id2, 84±5.7; P=0.15; Fig. 4E,F). In addition, the
absence of Id2 in ileal tumor epithelium did not alter the
proliferative capacity or the apoptosis rate in ApcΔ716 mice
(supplementary material Fig. S6). These data suggest that Id2
promotes tumor initiation with inhibition of apoptosis in the
intestinal crypt cells of Apc Id2 mice.
Loss of Id2 reduces the protein level of c-Myc and increases
the mRNA level of its antagonist Mxd1 in ileal crypt
epithelium of ApcΔ716 mice
To investigate the genes that could be involved in the inhibition of
ileal tumor formation in Apc Id2 mice, we next performed DNA
microarray analysis of ileal crypts that were isolated from ApcΔ716
and Apc Id2 mice. We then applied the following criteria to select
for such genes. First, the expression of the candidate gene was up-
or down-regulated by more than 8-fold in the microarray analysis.
Second, the expression levels of the candidate genes are changed
in the ileal crypt, yet not in the duodenum or jejunum. Third, the
candidate-genes have been implicated in tumor initiation.
Fig. 3. The Id2 protein is specifically
expressed in the intestinal crypt
epithelium. (A) H&E staining of normal small
intestinal tissues of ApcΔ716 mice before (left
panel) and after EDTA treatment to remove
villi (middle panel) and crypts (right panel).
The dashed line indicates the areas from
which the villi were removed. Closed
arrowheads indicate the areas from which the
crypt epithelium was removed. An open
arrowhead indicates the remaining crypt area.
Scale bars, 100 µm. (B) Expression of the Id2
protein analyzed by western blotting. Protein
samples were isolated from the normal
epithelium of villi and crypts of ApcΔ716 mice,
as shown in A. To confirm that the isolated
cells were of crypt cell origin, each samplewas
also subjected to western blotting of the c-Myc
protein. N, normal tissue; V, villus epithelium;
C, crypt epithelium. β-actin, loading control.
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Although 183 and 57 genes were up- and down-regulated,
respectively, by the Id2 loss (supplementary material Table S2),
Max dimerization protein 1 (Mxd1) was the only candidate gene
that met the three criteria. It is known that Mxd1 antagonizes c-
Myc function by competing with c-Myc for interaction with Max
(Ayer et al., 1993). It has been also reported that c-Myc is one of
the most important downstream targets of Wnt signaling (He et al.,
1998) and functions as a mediator of polyp growth and intestinal
cancer initiation (Ignatenko et al., 2006; Sansom et al., 2007;
Yekkala and Baudino, 2007). As shown in Fig. 5A, loss of Id2
increased the mRNA level of Mxd1 by ∼8 fold in the crypt
epithelium of the ileum but not in that of the duodenum or
jejunum. Induction of Mxd1 expression by Id2 deletion was also
observed at protein level, as shown by western blot (Fig. 5B). To
analyze the functional interaction between c-Myc and Mxd1, we
next determined the expression levels of c-Myc in the intestinal
crypt. Lack of Id2 did not affect the level of c-Myc mRNA
throughout the small intestinal tract (Fig. 5C). Importantly, loss of
Id2 down-regulated the protein level of c-Myc in the ileum but not
in the duodenum of ApcΔ716 mice (Fig. 5D). According to these
results, Id2 ablation also affects translation or stabilization of c-Myc
protein as well as transcription of Mxd1 mRNA. These results
Fig. 4. Loss of Id2 increased
apoptosis in the intestinal crypt of
ApcΔ716 mice. (A-D) Apoptotic cells
(closed arrowheads) in (A) the ileal
crypts and (C) villi of representative
ApcΔ716 and Apc Id2mice, visualized
by immunohistochemical analysis
using an antibody against cleaved
caspase-3. Closed arrowheads,
cleaved caspase-3 positive epithelial
cells; open arrowhead, cleaved
caspase-3 positive stromal cell.
Scale bars, 25 µm and 50 µm
(A and C, respectively).
Quantification of apoptotic cells in the
(B) ileal crypts and (D) villi of ApcΔ716
and Apc Id2 mice. (E) Cell
proliferation in the ileal crypts of
representative ApcΔ716 and
Apc Id2 mice, visualized by
immunohistochemical analysis using
an anti-Ki67 antibody. Scale bars,
25 µm. (F) Quantification of Ki67-
positive cells in the ileal crypts of
ApcΔ716 and Apc Id2 mice. The
results are given as means±s.d.
(n=3). *P<0.05.
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suggest that loss of Id2 inhibits tumor initiation through up-
regulation of Mxd1 mRNA and down-regulation of c-Myc protein.
DISCUSSION
We have shown here direct genetic evidence that Id2 plays a crucial
role in ileal tumor initiation in ApcΔ716 mice. Although Apc-
deficient mice have been widely analyzed, this study is the first
report to show ileum-specific reduction of tumor multiplicity in
these mice.
Id2 is highly expressed in the intestinal crypt epithelium and its
expression level is further increased in Apc-deficient adenoma
(Figs 1 and 3). It is known that Wnt signaling is activated in the
intestinal crypt and adenoma epithelial cells (Reya and Clevers,
2005). Consistent with these findings, our results have shown that
Tcf4 binds directly to the enhancer region of the Id2-gene promoter
(Fig. 1D). In addition, the encyclopedia of DNA elements
(ENCODE) data also showed that TCF4 binds to a region of the
human ID2 promoter that is homologous to the mouse Id2 enhancer
in HCT116, aWnt-signaling activated colon cancer cell line (Birney
et al., 2007) (supplementary material Fig. S1). These findings imply
that the expression of ID2/Id2 is stimulated as a downstream target
gene of Wnt signaling in the intestinal crypts and tumor epithelium
of both humans and mice.
Earlier studies have shown that Id2 contributes to tumor
proliferation. Overexpression of Id2 increases anchorage-independent
proliferation of both SW480 and HT29 colon cancer cells (Rockman
et al., 2001), and knockdown of Id2 decreases cell proliferation of
HCT116 cells (Gray et al., 2008). On the other hand, we have
demonstrated here that loss of Id2 inhibits tumor initiation rather than
tumor expansion in ApcΔ716 mice (Fig. 2B,C). Of note, adenoma
epithelial cells ofApcΔ716 mice do not carry additional mutations other
than Apc (Oshima et al., 1995a). In contrast, human colon cancer cell
lines that have been used in previous reports have several mutations
such as K-ras, p53 and transforming growth factor (TGF)-β type II
receptor (Gayet et al., 2001; Ijichi et al., 2001). It is therefore
conceivable that Id2 is involved in the proliferation of adenocarcinoma
epithelium beyond the stage examined here.
O’Brien et al. have reported that Id1 and Id3, other Id family
members, are expressed in colon cancer initiating cells and function
together with p21 to regulate their self-renewal capacity through cell
cycle restriction and DNA damage accumulation (O’Brien et al.,
2012). A more recent study has also shown that loss of Id1 inhibits
tumor initiation but does not affect tumor expansion in ApcMin/+
mice (Zhang et al., 2015). These findings and our study show that
Id2 plays an important role in intestinal tumor initiation in addition
to Id1 and Id3. This raises the possibility that Id1 and Id3
compensate for the function of Id2 in the duodenal- and jejunal-
tumor initiation that is not affected by the loss of Id2.
Our results suggest the possibility that the enhanced expression of
Mxd1 suppresses ileal-tumor initiation in Apc Id2mice (Fig. 5A,B).
Mxd1 belongs to the Max dimerization protein (Mxd) family of
proteins, which function as potent antagonists of c-Myc. It is
currently understood that Mxd1 competes with c-Myc for the
Fig. 5. Loss of Id2 reduces the protein level of c-Myc and increases the
mRNA level of its antagonist Mxd1 in the ileal crypts of ApcΔ716 mice.
(A) Expression of Mxd1 mRNA determined by qRT-PCR. Total RNA was
prepared from isolated crypts in the normal duodenum, jejunum and ileum of
ApcΔ716 and Apc Id2 mice. The results are given as means±s.d. (n=5).
**P<0.01. (B) Expression of Mxd1 protein determined by western blotting.
Protein samples were prepared from isolated crypts in the normal duodenum
and ileum of ApcΔ716 and Apc Id2 mice, as shown in Fig. 3A. The open and
closed arrowheads indicate nonspecific bands and specific Mxd1 bands.
A, ApcΔ716 mouse; AI, Apc Id2mouse. β-actin, loading control. (C) Expression
of c-Myc mRNA determined by qRT-PCR. Total RNA was prepared from
isolated crypts in the normal duodenum, jejunum and ileum ofApcΔ716 andApc
Id2 mice. The results are given as means±s.d. (n=5). (D) Expression of c-Myc
protein determined by western blotting. Protein samples were prepared from
isolated crypts, as shown in Fig. 3A. The open and closed arrowheads indicate
a nonspecific band and specific Id2 bands, respectively. A, ApcΔ716 mouse; AI,
Apc Id2 mouse. β-actin, loading control.
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transcription factor Max and for their recognition sequence E-box
(Cascón and Robledo, 2012; Diolaiti et al., 2015). The Mxd1–Max
heterodimer then functions as a transcriptional repressor at E-box
containing promoters and antagonizes the c-Myc–Max functions.
Consistently, overexpression of Mxd1 inhibits c-Myc/Ha-Ras
mediated co-transformation in rat embryo cells (Cerni et al.,
1995). In addition, loss of Mxd2, a member of the Mxd family,
resulted in susceptibility to tumorigenesis in squamous cell
carcinoma of the skin and malignant lymphoma (Schreiber-Agus
et al., 1998). It is therefore possible that Mxd1 contributes to the
tumor initiation of various tissues including ileum.
c-Myc is a critical mediator of adenoma initiation following Apc
loss (Ignatenko et al., 2006; Sansom et al., 2007; Yekkala and
Baudino, 2007). It was reported that targeted c-Myc deletion in the
intestinal epithelium reduced the tumor number ofApc heterozygotic
(ApcMin/+) mice with increases in apoptosis (Ignatenko et al., 2006).
Consistent with those studies, our results show that down-regulation
of c-Myc is accompanied by increases in apoptosis in the intestinal
crypt epithelium of Apc Id2 mice (Figs 4A,B and 5B). However, it
has also been reported that conditional Myc gene ablation decreases
the number of apoptotic cells in the intestinal epithelium of Apc
homozygotic (AhCre Apcfl/fl) mice (Sansom et al., 2007). This
discrepancy in the apoptotic phenotypes may be attributable to the
number of Apc mutant alleles in the normal intestinal epithelium.
Further studies are required to understand the precise roles of Id2,
c-Myc and Apc in apoptosis of intestinal epithelial cells.
Curiously, Id2 deletion decreased c-Myc protein levels, but not
mRNA levels, in the small-intestinal ileal crypt (Fig. 5C,D).
Importantly, it is known that Mxd1 can inhibit c-Myc function by
prevention of c-Myc–Max heterodimerization (Ayer et al., 1993).
This raises a possibility that inhibition of c-Myc–Max heterodimer
formation by enhanced expression of Mxd1 is involved in
destabilizing c-Myc protein. Thus, it is likely that Id2 promotes
tumor initiation through inhibition of the Mxd1–Max network and
activation of the c-Myc–Max.
In conclusion, we have demonstrated that Id2 is transcriptionally
controlled by Wnt signaling and contributes to the cell survival of
distal-intestinal crypt epithelium, which is accompanied by the
suppression of Mxd1 and stabilization of c-Myc.
MATERIALS AND METHODS
Mice
The knockout alleles of the Apc and Id2 genes have been described
previously (Oshima et al., 1995a; Yokota et al., 1999). The ApcΔ716 allele on
the C57BL/6 background was transferred to the 129/Sv genetic background
by backcrossing for more than 5 generations. Female ApcΔ716 mice on the
129/Sv background were then crossed twice with the Id2−/− mice on the
129/Sv background to generate double mutant Apc Id2−/− mice. All animal
experiments were carried out according to the protocols approved by the
Animal Care and Use committee of University of Fukui.
Cell culture
HCT116 and SW480 cells were obtained from the American Type Culture
Collection. The cells were grown at 37°C in 5% CO2 using DMEM (Wako,
Osaka, Japan) supplemented with 10% fetal bovine serum (Thermo Fisher
Scientifics, Waltham, MA, USA) and penicillin/streptomycin (Wako).
RT-PCR
The levels of specific mRNAs were determined by quantitative reverse-
transcription polymerase chain reaction (qRT-PCR) using a StepOnePlus
Real Time PCR system (Life Technologies, Foster, CA, USA). This analysis
was adapted from the previous study (Kakizaki et al., 2010). Primers used
were as follows: mouse Actb (forward, 5′-TGACAGGATGCAGAAGG-
AGA-3′; reverse, 5′-GCTGGAAGGTGGACAGTGAG-3′), mouse Id2
(forward, 5′-ACTCGCATCCCACTATCGTCAG-3′; reverse, 5′-TGCT-
ATCATTCGACATAAGCTCAGA-3′), mouse Id1 (forward, 5′-GGAG-
CTGAACTCGGAGTCTGAA-3′; reverse, 5′-GATCGTCGGCTGGAA-
CACA-3′), mouse Id3 (forward, 5′-GGAAATCCTGCAGCGTGTCATA-
3′; reverse, 5′-GAGATCACAAGTTCCGGAGTGA-3′), mouse c-Myc
(forward, 5′-CGAGCTGTTTGAAGGCTGGA-3′; reverse, 5′-GTCGC-
AGATGAAATAGGGCTGT-3′), mouse Mxd1 (forward, 5′-GACAGC-
GTGGGCTCTGTG-3′; reverse, 5′-CTGTGCCCTCCACATCCAC-3′),
mouse Cdx1 (forward, 5′-ACAGCCGGTACATCACTATCC-3′; reverse,
5′-GTTTACTTTGCGCTCCTTGG-3′), mouse Cdx2 (forward, 5′-TCT-
CCGAGAGGCAGGTTAAA-3′; reverse, 5′-CTGTGGAGGCTGTTGT-
TGCT-3′), and mouse Gata4 (forward, 5′-CCGGGCTGTCATCTCAC-
TAT-3′; reverse, 5′-CAGACAGCACTGGATGGATG-3′).
Laser microdissection
The mouse small intestinal epithelium was captured from frozen sections
using an AS LMD (Leica Microsystems, Bannockburn, IL, USA), and the
RNAs were purified using an RNeasy Micro Kit (Qiagen, Hilden,
Germany).
Western blotting
Dissected tissue samples were homogenized in RIPA lysis buffer containing
50 mM Tris-HCl, pH 7.4; 150 mM NaCl; 1 mM NaF; 1% NP-40; 0.25%
sodium deoxycholate; 1 mM sodium orthovanadate; 1 mM EDTA and a
protein protease inhibitor cocktail (Nacalai Tesque, Kyoto, Japan). Lysates
containing 10–40 µg of protein were separated by SDS-PAGE and
transferred to Hybond ECL Nitrocellulose membranes (GE Healthcare,
Buckinghamshire, UK). The membranes were blocked with Blocking One
(Nacalai Tesque) for 1 h at room temperature. The membranes were then
probed with the following antibodies: rabbit polyclonal anti-Id2 (sc-489;
Santa Cruz Biotechnology, Dallas, TX, USA), rabbit monoclonal anti-Id2
(D39E8, #3431; Cell Signaling Technology, Beverly, MA, USA), rabbit
polyclonal anti-Mxd1/Mad1 (sc-222; Santa Cruz Biotechnology), rabbit
monoclonal anti-c-Myc (D84C12, #5605; Cell Signaling Technology) and
mouse monoclonal anti-β-actin (Sigma-Aldrich, Saint Louis, MO, USA)
antibodies. After incubation with horseradish peroxidase-conjugated
secondary antibodies, bound proteins were detected by incubation with an
Immobilon chemiluminescent substrate (Millipore, Billerica, MA, USA).
Polyp number scoring
Dissected intestinal tissues were fixed with 4% paraformaldehyde. The
number of polyps was scored as described previously (Oshima et al.,
1995a).
Histological analysis
Dissected intestinal tissues were fixed with 4% paraformaldehyde, embedded
in paraffin wax and sectioned at a thickness of 4 µm. These sections were
stained with H&E or were processed for further immunostaining as described
previously (Oshima et al., 1995b). Rabbit polyclonal anti-cleaved caspase3
(Asp175, #9661; Cell Signaling Technology), anti-Ki67 (RM-9106; Thermo
Fisher Scientifics) were used as primary antibodies.
Classification of polyps
Dissected intestinal tissues were fixed with 4% paraformaldehyde,
embedded in paraffin wax and sectioned at a thickness of 4 µm at 40 µm
intervals throughout the tissue block and stained with anti-β-catenin (c2206;
Sigma-Aldrich) antibodies. Polyps were categorized as β-catenin-positive or
β-catenin-negative and scored for numbers.
DNA microarray
Normal ileal crypts were isolated from the ApcΔ716 and Apc Id2 mice as
previously described (Sato et al., 2009). Total RNA was purified using the
RNeasy Micro Kit (Qiagen). Gene expression profiles were analyzed using
the 3D-Gene Mouse Oligo Chip 24k (Toray Industries, Kanagawa, Japan).
ChIP-PCR
ChIP assays were performed using the ChIP-it high sensitivity kit (Active
Motif, Carlsbad, CA, USA) according to the manufacturer’s instructions.
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Intestinal polyps from ApcΔ716 mice were fixed with 1% formaldehyde for
15 min at room temperature. Isolated nuclei from the mouse intestinal
polyps were sonicated using a Biorupter (Cosmo Bio Co. Ltd., Tokyo,
Japan). After centrifugation to remove debris, chromatin samples were
incubated with rabbit monoclonal anti-TCF4 antibody (C48H11, #2569;
Cell Signaling Technology) or normal rabbit IgG (#2729; Cell Signaling
Technology) overnight at 4°C. The qPCR analysis of immunoprecipitated
DNA fragments was performed using KOD SYBER qPCRMix (TOYOBO,
Osaka, Japan) with the following primer set: mouse Axin2 promoter
(forward, 5′-CTCGCATACCTCCCTTCC-3′; reverse 5′-TTCCAGCAGT-
CACTAGGC-3′), mouse Id2 promoter-1 (forward, 5′-GGGTGCTGAAA-
GATTCCAAA-3′; reverse 5′-GTGGCAAAGTGATGCGATTA-3′), mouse
Id2 promoter-2 (forward, 5′-TCAGTACCGCAGAGATGCAA-3′; reverse
5′-GCGGAACAGATTTTGTTTTGA), or mouse Id2 promoter-3 (forward,
5′-TTTTGGAGTCAAAGCCATCC-3′; reverse 5′-AGACCTTGCCAAAG-
CAAAAG-3′). Results are presented as percentage immunoprecipitated over
input and are representative of three independent experiments.
Vector construction and site-directed mutagenesis
The full length, TCF4/TCF7L2 cDNAs were isolated by PCR-based
cloning techniques using the following primer sets: TCF4/TCF7L2
(forward, 5′-CTTCCTCCTTCATTTTTCTT-3′; reverse, 5′-CAATGAAC-
TCGATAAACATC-3′). The TCF4/TCF7L2 cDNAs was inserted into
pcDNA6/V5-HisA (Invitrogen, Grand Island, NY, USA) for transient
expression. The putative Id2 enhancer region was cloned by PCR
amplification from the genomic DNA from mouse tail using the forward
primer 5′-GCGTTTCCAGGCTGACTTAC-3′ and the reverse primers
5′-AGACCTTGCCAAAGCAAAAG-3′, and inserted into pGL4.10
luciferase vector (Promega, Madison, WI, USA) to generate the reporter
construct (Fig. 1C). The pCMV6-XL5 expression vector carrying the
CTNNB1 was obtained from T. Akiyama (The University of Tokyo). Site-
directed mutagenesis for mutating the CTNNB1 was performed using
PrimeSTAR mutagenesis Basal kit (TaKaRa, Shiga, Japan) with the
following oligomers: 5′-CAGTCTTACCTGGACTaTGGAATCCATTCT-
GGTG-3′ and 5′-CACCAGAATGGATTCCAtAGTCCAGGTAAGACT-
G-3′. The lower cases indicate the mutated sequences in the CTNNB1
phosphorylation sites. The mutated cDNA were subcloned into pcDNA6/
V5-HisA.
Luciferase reporter gene assay
The luciferase assay protocol was adapted from a previous study (Kakizaki
et al., 2010). HCT116 or SW480 cells were seeded into MP-24 tissue culture
plates at a density of 5×104 cells per well. The cultures were transfected with
100 ng of luciferase reporter gene constructs, 200 ng of a pcDNA6/V5-HisA
expression vector carrying the CTNNB1 S33A mutant encoding the active
form of β-catenin and TCF4, and 2 ng of the hRluc-CMV vector (Promega),
using LipofectaminLTX (Life Technologies). After 24 h of incubation, the
cultures were washed once with ice-cold PBS and then lysed in 100 µl of
Passive lysis buffer (Promega) according to the manufacturer’s protocol.
Firefly and Renilla luciferase activities were determined using the Dual-
Luciferase Reporter Assay System (Promega) with a MITHORAS LB 940
(BertholdBiolumat,BadWildbad,Germany). Firefly luciferase activitieswere
normalized against the Renilla luciferase activities.
Statistical analysis
Thevalues are shownasmeans±s.d.Datawere analyzed using a Student’s t-test
orANOVA.P-values smaller than0.05were considered statisticallysignificant.
Accession numbers
Microarray hybridization data have been deposited in the GEO database
with accession code GSE66480.
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(1995). Differential effects by Mad and Max on transformation by cellular and viral
oncoproteins. Oncogene 11, 587-596.
Diolaiti, D., McFerrin, L., Carroll, P. A. and Eisenman, R. N. (2015). Functional
interactions among members of the MAX and MLX transcriptional network during
oncogenesis. Biochim. Biophys. Acta 1849, 484-500.
Fodde, R., Smits, R. and Clevers, H. (2001). APC, signal transduction and genetic
instability in colorectal cancer. Nat. Rev. Cancer 1, 55-67.
Gayet, J., Zhou, X.-P., Duval, A., Rolland, S., Hoang, J.-M., Cottu, P. and
Hamelin, R. (2001). Extensive characterization of genetic alterations in a series of
human colorectal cancer cell lines. Oncogene 20, 5025-5032.
Ghosh, H. S., Ceribelli, M., Matos, I., Lazarovici, A., Bussemaker, H. J.,
Lasorella, A., Hiebert, S. W., Liu, K., Staudt, L. M. and Reizis, B. (2014). ETO
family protein Mtg16 regulates the balance of dendritic cell subsets by repressing
Id2. J. Exp. Med. 211, 1623-1635.
Gray,M.J.,Dallas,N.A.,VanBuren,G.,Xia,L., Yang,A.D.,Somcio,R.J.,Gaur,P.,
Mangala, L. S., Vivas-Mejia, P. E., Fan,F. et al. (2008). Therapeutic targeting of Id2
reduces growth of human colorectal carcinoma in the murine liver. Oncogene 27,
7192-7200.
He, T.-C., Sparks, A. B., Rago, C., Hermeking, H., Zawel, L., da Costa, L. T.,
Morin, P. J., Vogelstein, B. and Kinzler, K. W. (1998). Identification of c-MYC as
a target of the APC pathway. Science 281, 1509-1512.
Ignatenko, N. A., Holubec, H., Besselsen, D. G., Blohm-Mangone, K. A., Padilla-
Torres, J. L., Nagle, R. B., de Alboránç, I. M., Guillen-R, J. M. andGerner, E.W.
(2006). Role of c-Myc in intestinal tumorigenesis of the ApcMin/+ mouse. Cancer
Biol. Ther. 5, 1658-1664.
Ijichi, H., Ikenoue, T., Kato, N., Mitsuno, Y., Togo, G., Kato, J., Kanai, F.,
Shiratori, Y. and Omata, M. (2001). Systematic analysis of the TGF-beta-Smad
signaling pathway in gastrointestinal cancer cells. Biochem. Biophys. Res.
Commun. 289, 350-357.
Kakizaki, F., Aoki, K., Miyoshi, H., Carrasco, N., Aoki, M. and Taketo, M. M.
(2010). CDX transcription factors positively regulate expression of solute carrier
family 5, member 8 in the colonic epithelium. Gastroenterology 138, 627-635.
Kinzler, K. W. and Vogelstein, B. (1996). Lessons from hereditary colorectal
cancer. Cell 87, 159-170.
O’Brien, C. A., Kreso, A., Ryan, P., Hermans, K. G., Gibson, L., Wang, Y.,
Tsatsanis, A., Gallinger, S. and Dick, J. E. (2012). ID1 and ID3 regulate the self-
renewal capacity of human colon cancer-initiating cells through p21. Cancer Cell
21, 777-792.
Oshima, M., Oshima, H., Kitagawa, K., Kobayashi, M., Itakura, C. and Taketo,
M. M. (1995a). Loss of Apc heterozygosity and abnormal tissue building in
nascent intestinal polyps in mice carrying a truncated Apc gene. Proc. Natl. Acad.
Sci. USA 92, 4482-4486.
Oshima, M., Oshima, H., Kobayashi, M., Tsutsumi, M. and Taketo, M. M.
(1995b). Evidence against dominant negative mechanisms of intestinal polyp
formation by Apc gene mutations. Cancer Res. 55, 2719-2722.
Perk, J., Iavarone, A. and Benezra, R. (2005). Id family of helix-loop-helix proteins
in cancer. Nat. Rev. Cancer 5, 603-614.
1000









Powell, S. M., Zilz, N., Beazer-Barclay, Y., Bryan, T. M., Hamilton, S. R.,
Thibodeau, S. N., Vogelstein, B. and Kinzler, K. W. (1992). APC mutations
occur early during colorectal tumorigenesis. Nature 359, 235-237.
Reya, T. and Clevers, H. (2005). Wnt signalling in stem cells and cancer. Nature
434, 843-850.
Rockman, S. P., Currie, S. A., Ciavarella, M., Vincan, E., Dow, C., Thomas,
R. J. S. and Phillips, W. A. (2001). Id2 Is a Target of the β-catenin/T cell factor
pathway in colon carcinoma. J. Biol. Chem. 276, 45113-45119.
Russell, R. G., Lasorella, A., Dettin, L. E. and Iavarone, A. (2004). Id2 drives
differentiation and suppresses tumor formation in the intestinal epithelium.Cancer
Res. 64, 7220-7225.
Ruzinova, M. B. and Benezra, R. (2003). Id proteins in development, cell cycle and
cancer. Trends Cell Biol. 13, 410-418.
Sansom, O. J., Meniel, V. S., Muncan, V., Phesse, T. J., Wilkins, J. A., Reed,
K. R., Vass, J. K., Athineos, D., Clevers, H. and Clarke, A. R. (2007). Myc
deletion rescues Apc deficiency in the small intestine. Nature 446, 676-679.
Sato, T., Vries, R. G., Snippert, H. J., van de Wetering, M., Barker, N., Stange,
D. E., van Es, J. H., Abo, A., Kujala, P., Peters, P. J. et al. (2009). Single Lgr5
stem cells build crypt-villus structures in vitro without a mesenchymal niche.
Nature 459, 262-265.
Schreiber-Agus, N., Meng, Y., Hoang, T., Hou, H. Jr., Chen, K., Greenberg, R.,
Cordon-Cardo, C., Lee, H. W., DePinho, R. A. (1998). Role of Mxi1 in ageing
organ systems and the regulation of normal and neoplastic growth. Nature 393,
483-487.
Taketo, M. M. and Edelmann, W. (2009). Mouse models of colon cancer.
Gastroenterology 136, 780-798.
Wilson, J. W., Deed, R.W., Inoue, T., Balzi, M., Becciolini, A., Faraoni, P., Potten,
C. S. and Norton, J. D. (2001). Expression of Id helix-loop-helix proteins in
colorectal adenocarcinoma correlates with p53 expression and mitotic index.
Cancer Res. 15, 8803-8810.
Yekkala, K. and Baudino, T. A. (2007). Inhibition of intestinal polyposis with
reduced angiogenesis in ApcMin/+ mice due to decreases in c-Myc expression.
Mol. Cancer Res. 5, 1296-1303.
Yokota, Y. (2001). Id and development. Oncogene 20, 8290-8298.
Yokota, Y. and Mori, S. (2002). Role of Id family proteins in growth control. J. Cell
Physiol. 190, 21-28.
Yokota, Y., Mansouri, A., Mori, S., Sugawara, S., Adachi, S., Nishikawa, S.-I.
and Gruss, P. (1999). Development of peripheral lymphoid organs and
natural killer cells depends on the helix-loop-helix inhibitor Id2. Nature 397,
702-706.
Zhang, N., Subbaramaiah, K., Yantiss, R. K., Zhou, X. K., Chin, Y., Benezra, R.
and Dannenberg, A. J. (2015). Id1 deficiency protects against tumor formation in
ApcMin/+ mice but not in a mouse model of colitis-associated colon cancer.
Cancer Prev. Res. 8, 303-311.
RESEARCH ARTICLE Biology Open (2015) 4, 993-1001 doi:10.1242/bio.012252
1001
B
io
lo
g
y
O
p
en
